AB Biosciences Competitors and Similar CompaniesClear all
PDL BioPharma's competitors and similar companies include Outlook Therapeutics.
 PDL BioPharma PDL BioPharma, Inc. engages in intellectual property asset management, and patent portfolio and related assets investment activities. |  Outlook Therapeutics Outlook Therapeutics (formerly Oncobiologics) is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics. | |
Founding Date | Founding Date 1986 | Founding Date 2011 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Incline Village, US HQ | Locations Woodbridge Township, US HQ |
Employees | Employees 10521% increase | Employees 1726% decrease |
Valuation ($) | Valuation ($) 282.1 m | Valuation ($) 136.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $54.8m (FY, 2019) | Revenue (est.) $1.4m (FY, 2025) |
Cost of goods | Cost of goods $53.6m (FY, 2019) | Cost of goods $1.4m (FY, 2025) |
Gross profit | Gross profit $1.1m (FY, 2019) | Gross profit $57.2k (FY, 2025) |
Net income | Net income ($70.7m) (FY, 2019) | Net income ($62.4m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Outlook Therapeutics
HQ
Woodbridge Township, US
Employees
17↓ 26% decrease
Outlook Therapeutics (formerly Oncobiologics) is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics.
View company